Adrenergic Drug Market Size

  • Report ID: 2541
  • Published Date: Nov 19, 2025
  • Report Format: PDF, PPT

Adrenergic Drug Market Outlook:

Adrenergic Drug Market size was over USD 3.34 billion in 2025 and is projected to reach USD 6.04 billion by 2035, witnessing around 6.1% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of adrenergic drug is evaluated at USD 3.52 billion.

The growth of this sector is poised to be encouraged by a surge in number of cases of COVID-19. For instance, worldwide coronavirus (COVID-19) incidence were almost 767 million as of June 13, 2023. Hence, the market demand for adrenergic drug is set to increase.

Adrenergic drug has been increasingly used for the treatment of patients suffering from different allergic reactions such as food allergies. According to the Food and Agriculture Organization of the United Nations, nearly 220 million people across the globe have food allergies.


Adrenergic Drug Market Size

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of adrenergic drug is evaluated at USD 3.52 billion.

The global adrenergic drug market size surpassed USD 3.34 billion in 2025 and is projected to witness a CAGR of over 6.1%, crossing USD 6.04 billion revenue by 2035.

By 2035, North America is set to capture a 35% share of the adrenergic drug market during 2026–2035, due to the rising prevalence of chronic diseases.

Key players in the market include Pfizer, Inc., Novartis AG, GSK plc., AstraZeneca, Merck & Co., Inc., Sanofi, Johnson & Johnson, Inc., Eli Lilly and Company, F. Hoffmann-La Roche Ltd, Viatris Inc.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos